Core Viewpoint - The inclusion of the HPV vaccine in China's national immunization program starting from November 10, 2025, will allow eligible residents to receive the vaccine for free, significantly enhancing public health efforts against cervical cancer and related diseases [1][2][4]. Group 1: Policy and Implementation - The HPV vaccine will be provided free of charge to girls born on or after November 10, 2011, who are 13 years old, with a recommended two-dose schedule [4][6]. - The addition of the HPV vaccine increases the total number of vaccines in the national immunization program to 15, which aims to improve vaccination rates and public health [2][4]. Group 2: Market Impact - The procurement price of the bivalent HPV vaccine has decreased significantly, with a reported price of 86 yuan per dose in March 2024 and a budgeted price of 27.5 yuan per dose for 2025 [5]. - The government’s centralized procurement is expected to drive a substantial increase in HPV vaccine sales and market penetration, benefiting companies like Watson Bio, which has sufficient production capacity to meet demand [5][6]. Group 3: Health Benefits and Efficacy - Vaccination can prevent over 70% of cervical cancer cases and reduce the incidence of other HPV-related diseases, as evidenced by experiences from other countries [4][6]. - Research indicates that girls aged 9-14 produce antibody levels more than twice that of those over 15 when vaccinated, making this age group a strategic target for vaccination [6][9]. Group 4: Vaccine Options and Recommendations - There are three types of HPV vaccines available: bivalent, quadrivalent, and nonavalent, with the nonavalent vaccine providing the broadest protection against various HPV strains [7][9]. - The guidelines suggest that women who have completed the bivalent or quadrivalent vaccination do not need to receive the nonavalent vaccine unless they choose to do so based on personal circumstances [9].
这些女孩免费打HPV疫苗，还用花钱打九价吗？
3 6 Ke·2025-11-10 10:59